SLC44A1 and pachyonychia congenita: The results showed that five FmRNAs, including MET, RACGAP1, SLC44A1, TBL1XR1, and TRPS1, seemed to have a protective effect, and the higher the expression level of these mRNAs, the better the prognosis of PC patients.